| 1 |
规范指导临床办公室国家百万减残工程, 中国老年医学学会脑血管病分会. 远隔缺血适应防治缺血性脑血管病中国专家共识 [J]. 中华医学杂志, 2021, 101(25): 1953-1967.
|
| 2 |
De Meyer SF, Denorme F, Langhauser F, et al. Thromboinflammation in stroke brain damage [J]. Stroke, 2016, 47(4): 1165-1172.
|
| 3 |
Stoll G, Nieswandt B. Thrombo-inflammation in acute ischaemic stroke-implications for treatment [J]. Nat Rev Neurol, 2019, 15(8): 473-481.
|
| 4 |
Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms [J]. Blood, 2019, 133(9): 906-918.
|
| 5 |
Pham M, Helluy X, Kleinschnitz C, et al. Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla [J]. PLoS One, 2011, 6(4): e18386.
|
| 6 |
Chou ML, Babamale AO, Walker TL, et al. Blood-brain crosstalk: the roles of neutrophils, platelets, and neutrophil extracellular traps in neuropathologies [J]. Trends Neurosci, 2023, 46(9): 764-779.
|
| 7 |
Stuckey SM, Ong LK, Collins-Praino LE, et al. Neuroinflammation as a key driver of secondary neurodegeneration following stroke? [J]. Int J Mol Sci, 2021, 22(23): 13101.
|
| 8 |
Constantinescu-Bercu A, Grassi L, Frontini M, et al. Activated α(IIb)β(3) on platelets mediates flow-dependent NETosis via SLC44A2 [J]. Elife, 2020, 9: e53353.
|
| 9 |
Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo [J]. Cell, 2009, 139(6): 1143-1156.
|
| 10 |
Sonnweber T, Pizzini A, Nairz M, et al. Arachidonic acid metabolites in cardiovascular and metabolic diseases [J]. Int J Mol Sci, 2018, 19(11): 3285.
|
| 11 |
Darbousset R, Thomas GM, Mezouar S, et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation [J]. Blood, 2012, 120(10): 2133-2143.
|
| 12 |
Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation [J]. Trends Mol Med, 2004, 10(4): 171-178.
|
| 13 |
Asgari A, Jurasz P. Role of nitric oxide in megakaryocyte function [J]. Int J Mol Sci, 2023, 24(9): 8145.
|
| 14 |
Machlus KR, Johnson KE, Kulenthirarajan R, et al. CCL5 derived from platelets increases megakaryocyte proplatelet formation [J]. Blood, 2016, 127(7): 921-926.
|
| 15 |
Gorudko IV, Sokolov AV, Shamova EV, et al. Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entry [J]. Biol Open, 2013, 2(9): 916-923.
|
| 16 |
Wagner DD, Heger LA. Thromboinflammation: from atherosclerosis to COVID-19 [J]. Arterioscler Thromb Vasc Biol, 2022, 42(9): 1103-1112.
|
| 17 |
Thiam HR, Wong SL, Wagner DD, et al. Cellular mechanisms of NETosis [J]. Annu Rev Cell Dev Biol, 2020, 36: 191-218.
|
| 18 |
Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis [J]. Proc Natl Acad Sci U S A, 2010, 107(36): 15880-15885.
|
| 19 |
Zhu C, Tian B. Intracranial atherosclerotic plaques identified on vessel wall imaging are associated with increased risk of first-ever stroke in a large Chinese cohort [J]. Eur J Neurol, 2023, 30(12): 3635-3636.
|
| 20 |
Roth S, Singh V, Tiedt S, et al. Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke [J]. Sci Transl Med, 2018, 10(432): eaao1313.
|
| 21 |
Zietz A, Gorey S, Kelly PJ, et al. Targeting inflammation to reduce recurrent stroke [J]. Int J Stroke, 2023: 17474930231207777.
|
| 22 |
Pircher J, Engelmann B, Massberg S, et al. Platelet-neutrophil crosstalk in atherothrombosis [J]. Thromb Haemost, 2019, 119(8): 1274-1282.
|
| 23 |
Libby P. Targeting inflammatory pathways in cardiovascular disease: the inflammasome, interleukin-1, interleukin-6 and beyond [J]. Cells, 2021, 10(4): 951.
|
| 24 |
Ridker PM. The time to initiate anti-inflammatory therapy for patients with chronic coronary atherosclerosis has arrived [J]. Circulation, 2023, 148(14): 1071-1073.
|
| 25 |
Braun LJ, Stegmeyer RI, Schäfer K, et al. Platelets docking to VWF prevent leaks during leukocyte extravasation by stimulating Tie-2 [J]. Blood, 2020, 136(5): 627-639.
|
| 26 |
Szepanowski RD, Haupeltshofer S, Vonhof SE, et al. Thromboinflammatory challenges in stroke pathophysiology [J]. Semin Immunopathol, 2023, 45(3): 389-410.
|
| 27 |
Zhang X, Gong P, Zhao Y, et al. Endothelial caveolin-1 regulates cerebral thrombo-inflammation in acute ischemia/reperfusion injury [J]. EBioMedicine, 2022, 84: 104275.
|
| 28 |
Cui J, Li H, Chen Z, et al. Thrombo-inflammation and immunological response in ischemic stroke: focusing on platelet-tregs interaction [J]. Front Cell Neurosci, 2022, 16: 955385.
|
| 29 |
Gill D, Veltkamp R. Dynamics of T cell responses after stroke [J]. Curr Opin Pharmacol, 2016, 26: 26-32.
|
| 30 |
Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature [J]. Blood, 2013, 121(4): 679-691.
|
| 31 |
Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology [J]. Physiol Rev, 2007, 87(1): 245-313.
|
| 32 |
Nieswandt B, Kleinschnitz C, Stoll G. Ischaemic stroke: a thrombo-inflammatory disease? [J]. J Physiol, 2011, 589(17): 4115-4123.
|
| 33 |
Santos-Lima B, Pietronigro EC, Terrabuio E, et al. The role of neutrophils in the dysfunction of central nervous system barriers [J]. Front Aging Neurosci, 2022, 14: 965169.
|
| 34 |
戚智锋, 罗玉敏, 刘克建. 自由基和基质金属蛋白酶介导脑缺血血脑屏障损伤的研究进展 [J]. 生物物理学报, 2012, 28(5): 383-391.
|
| 35 |
Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology [J]. Nat Rev Cardiol, 2021, 18(9): 666-682.
|
| 36 |
Zhang Z, Shen C, Fang M, et al. Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke [J]. Cell Mol Life Sci, 2022, 79(5): 240.
|
| 37 |
Hernández-Jiménez M, Abad-Santos F, Cotgreave I, et al. Safety and efficacy of ApTOLL in patients with ischemic stroke undergoing endovascular treatment: a phase 1/2 randomized clinical trial [J]. JAMA Neurol, 2023, 80(8): 779-788.
|
| 38 |
Ramiro L, Simats A, García-Berrocoso T, et al. Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management [J]. Ther Adv Neurol Disord, 2018, 11: 1756286418789340.
|
| 39 |
贾建平, 陈生弟. 神经病学 [M]. 8版. 北京: 人民卫生出版社, 2021: 204-207.
|
| 40 |
McCabe JJ, Camps-Renom P, Giannotti N, et al. Carotid plaque inflammation imaged by PET and prediction of recurrent stroke at 5 years [J]. Neurology, 2021, 97(23): e2282-e2291.
|
| 41 |
Foschi M, Padroni M, Abu-Rumeileh S, et al. Diagnostic and prognostic blood biomarkers in transient ischemic attack and minor ischemic stroke: an up-to-date narrative review [J]. Stroke Cerebrovasc Dis, 2022, 31(3): 106292.
|
| 42 |
Yang M, Pan Y, Li Z, et al. Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR II [J]. Front Neurol, 2019, 10: 370.
|
| 43 |
Whiteley W, Wardlaw J, Dennis M, et al. Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study [J]. Cerebrovasc Dis, 2011, 32(2): 141-147.
|
| 44 |
Khandkar C, Vaidya K, Patel S. Colchicine for stroke prevention: a systematic review and meta-analysis [J]. Clin Ther, 2019, 41(3): 582-590.
|
| 45 |
Wang Y, Li J, Johnston SC, et al. Colchicine in high-risk patients with acute minor-to-moderate ischemic stroke or transient ischemic attack (CHANCE-3): rationale and design of a multicenter randomized placebo-controlled trial [J]. Int J Stroke, 2023, 18(7): 873-878.
|